Pancreatic cancer remains one of the deadliest malignancies, due in large part to challenges with early diagnosis.  Advanced ...

Patients — and their doctors — have been desperate for a more effective pancreatic cancer treatment for decades. Now one ...

Pancreatic cancer remains one of the most difficult cancers to treat, with many patients facing a high risk of recurrence ...

An experimental drug from Revolution Medicines that nearly ​doubled survival time for patients with advanced pancreas cancer ...

Artificial intelligence detected hidden signs of pancreatic cancer in normal scans long before a medical diagnosis was made.

New research shows that the same genes are active in pancreatic cancer, obesity and diabetes, helping to explain why people ...

An artificial intelligence model from the Mayo Clinic detected early signs of possible pancreatic cancer on scans up to two ...

Former Sen. Ben Sasse, 54, called daraxonrasib "a miracle drug" that was allowing him to live longer and with less pain.

Mayo Clinic's AI model identifies invisible signs of pancreatic cancer on routine CT scans, potentially transforming early ...

The targeted RAS inhibitor daraxonrasib was found to be safe and showed signs of efficacy in patients with previously treated ...

The FDA said it will grant some patients early access to Revolution Medicines' experimental pancreatic cancer drug ...